Hepatitis B surface antigen (HBsAg) prevalence in Central African Republic
Central African Republic: Hepatitis B surface antigen (HBsAg) prevalence was 5.3% in 2024. ▼ Falling
Hepatitis B surface antigen (HBsAg) prevalence in Central African Republic, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hepatitis b surface antigen (hbsag) prevalence in Central African Republic is 5.3%, measured in 2024. That is the lowest value across all 10 years on record.
That represents a change of down 10.2% on the previous year and down 46.5% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Central African Republic peaked at 10.5% in 2017 and was at its lowest, 5.3%, in 2024.
Central African Republic ranks 1st of 194 countries on this measure, in the top 10%.
Hepatitis B surface antigen (HBsAg) prevalence in Central African Republic, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 9.9% | — |
| 2016 | 10.0% | +1.0% |
| 2017 | 10.5% | +5.0% |
| 2018 | 10.2% | -2.9% |
| 2019 | 9.5% | -6.9% |
| 2020 | 8.5% | -10.5% |
| 2021 | 7.7% | -9.4% |
| 2022 | 7.4% | -3.9% |
| 2023 | 5.9% | -20.3% |
| 2024 | 5.3% | -10.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 10.0% | 9.5% | 10.5% | 5 |
| 2020s | 7.0% | 5.3% | 8.5% | 5 |
Countries ranked near Central African Republic
More health data for Central African Republic
- Un projection of annual infant deaths, annual growth rate -1.88 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.15 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 887.2 deaths per 1,000 people (2090)
- Number of infants who die before age 1 5,728 deaths (2100)
- Population ages 0-14, female, annual growth rate 2.73 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0.0004 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.2413 units per person (2025)
- Population ages 0-14, male, annual growth rate 2.77 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0.0004 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.2455 units per person (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Central African Republic?
- Hepatitis b surface antigen (hbsag) prevalence in Central African Republic was 5.3% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Central African Republic?
- The highest recorded value was 10.5% in 2017.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Central African Republic?
- The lowest recorded value was 5.3% in 2024.
- How does Central African Republic rank for hepatitis b surface antigen (hbsag) prevalence?
- Central African Republic ranks 1st out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Central African Republic?
- Over the last ten years it is down 46.5%. The long-run trend across the full record is falling.
- Where does this Central African Republic data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).